ADCYAP1 and diabetic kidney disease: Indeed, other sparse pieces of evidence inferring on the potential beneficial effects of PACAP have been previously described in the kidney using in vitro models, such as vasodilation and renin secretion [76] and protective effects against hydrogen peroxide-induced oxidative stress [72]. In vivo models of diabetic nephropathy have also proven the protective role of PACAP in this pathological condition.